Kai, Keiko
Tominaga, Naoto http://orcid.org/0000-0002-3699-7418
Koitabashi, Kenichiro
Ichikawa, Daisuke
Shibagaki, Yugo
Article History
Received: 10 May 2018
Accepted: 6 January 2019
First Online: 14 January 2019
Compliance with ethical standards
:
: Honoraria: Naoto Tominaga (Otsuka Pharmaceutical), and Yugo Shibagaki (Novartis pharma, Otsuka Pharmaceutical). Research funding: Yugo Shibagaki (Teijin Pharma, Otsuka Pharmasuitical, Takeda, Kyowa-Hakko Kirin).
: This article does not contain any studies with human participants performed by any of the authors.
: The design of this report was approved and the requirement for informed consent was waived by our institutional review board (No. 3950).